SSX-2026

9th Annual Conference of the Society for the Study of Xenobiotics
"New Approaches to navigate Complexities in Drug Discovery and Development"
Download Program Brochure

Registration Date


Early Registration Closes On
10th February 2026

Mentorship Icon
Mentorship
Sessions
Attractive Icon
Attractive
poster prizes
Oral Icon
Oral
Presentation Prizes
20 February 2026
21 February 2026
22 February 2026
SSX-2026 Conference Agenda
Time Speaker Co-Chairs
08:00 - 08:45 Registration and breakfast
08:45 - 09:15 Inauguration Bharath S and Anandi Karumbati
9:15-10:05 Keynote 1: Dr. Ashok Venkitaraman, Distinguished Professor of Medicine, NUS, Chief Scientist, A-Star, Singapore Anandi Karumbati
Session 1 - ADME considerations for drug discovery and development
10:05 - 10:40 Dr. Raju Subramanian, Executive Director, Gilead Sciences, USA
10:40 - 10:55 Group Photo
10:55 - 11:10 Tea Break
11:10 - 11:30 Sponsor talk (Eurofins) Geetha T and Krishna Iyer
11:30 - 11:50 Sponsor talk - Krishgen
11:50 - 12:25 Dr. Upendra Argikar, DMPK Leader, Gates Medical Research Institute, USA
12:25 - 13:00 Dr. Devang Shah, Director, Bristol Myers Squibb, Bangalore
13:00 - 15:30 Lunch, Poster & Exhibitor Session
Session 2: AI/ML considerations in drug discovery and Development.
15:30 - 16:05 Dr. Shridhar Narayanan, Founder Peptris/ FNDR, Banglaore
16:05 - 16:40 Dr. Priyaranjan Pattanaik, Vice President, Syngene International Limited, Bangalore Vishwottam Kandikere and Judy Jays
16:40 - 17:15 Dr. Ramanathan Sowdhamini , Senior Professor, National Center for Biological Sciences, Bangalore
Session 3: Advancements in Understanding Solid state of Pharmaceuticals
15:30 - 16:05 Dr. Arvind K Bansal, Professor, Department of Pharmaceutics NIPER, Mohali
16:05 - 16:40 Dr.Ramanaiah Chennuru, Director and Head, COE-Polymorphism and Crystallization, Cipla Ltd. Amol D and Basavraj
16:40 - 17:15 Dr. Sharmistha Paldatta, Scientist & Lead, Solid State Screening Group, Dr. Reddy's Laboratories, Hyderabad
Continuation of Common Session
17:15 - 17:50 Special session on "Resilience Decoded" by Dr. Sujata Kelkar
17:50 - 18:10 Preparation for the cultural program Gauri and Manasa Deepa
18:10 - 19:30 Cultural Program
19:30 - 20:30 Networking and Dinner at Ramaiah University
Time Topic Co-Chairs
08:00 - 08:30 Breakfast
08:30 - 09:20 Keynote 2: Dr. Stephan Bromacher, Novartis Hemant Bhutani
Session 4: Technological Innovations in Drug Discovery and Development
09:20 - 09:55 Dr Manojkumar Singh, Senior Vice President, Analytical Research and Development, Microlabs
09:55 - 10:30 Dr. Sajesh Thomas, Associate Professor, IIT, Delhi Lakshmikant Bajpai and Rajesh Gandhi
10:30 - 11:05 Dr. Sunil Kumar Panigrahi, Associate Vice President, Aurigene Pharmaceutical Services Ltd.
11:05 - 11:20 Tea Break
11:20 - 11:40 Sponsor talk - Corning
11:40 - 12:00 Sponsor talk (Aragen) Shashyendra Singh
12:05 - 12:20 Felicitation of sponsors
12:20 - 13:30 Student talks (6 Talks) Amol Raje and Deveshwaran
13:30 - 16:00 Lunch, Poster & Exhibitor Session
Session 5: Next Generation Therapeutics
16:00 - 16:35 Dr. Maloy Ghosh CSO, Zumutor Biologics
16:35 - 17:10 Dr. Arati Ramesh, Principal Scientist, Tata Institute of Genomics and Society Rajkapoor and Swaminathan Sethu
17:10 - 17:45 Dr. Narmada B C , Lead Scientist, Vantage
Session 6: Intricacies in the Development of Next Generation Therapeutics
16:00 - 16:35 Dr. Ravi Shah, Professor & Head, Department of Pharmaceutical Analysis, NIPER, Ahmedabad
16:35 - 17:10 Dr. M. V. Narendra Kumar Talluri, Director, Daicel Chiral Technologies Sakthidevan and J. Anbu
17:10 - 17:45 Dr. Manikandan R, Senior Vice President, Analytical Research and Development, Granules India
Continuation of Common Session
17: 45 -18:30 Panel Discussion. Fireside chat with Pathbreakers
  • 1. Chandra Siddamadappa, Vipragen
  • 2. Vijay Ivaturi, Pumas AI
  • 3. Srividya Janani, Biomoneta
  • 4. Gopi Kadiyala, Kyntox Biotech
T. Thanga Mariappan
Time Topic Co-Chairs
08:00 - 08:30 Breakfast
Session 7: Advances in Clinical Pharmacology
08:30 - 09:05 Hiroyuki Kusuhara, University of Tokyo, President of JSSX
09:05 - 09:40 Rama Sivasubramanian, Head of R&D – India, Teva Pharmaceuticals Premkumar and Ashoka Babu V L
09:40 - 10:15 Dr. Sahadev Shankarappa, Professor, Ramaiah University
10:15 -10:30 Tea Break
Session 8: Case studies in Drug Discovery and Development
10:30 - 11:05 Kumar Nemmani, Associate Vice President, Sun Pharma
11:05 - 11:40 Mr. Prasad Chodavarupu, Founder and Managing Director, Aganitha Cognitive Sciences Surulivel Rajan and Purnima Ashok
11:40 - 12:15 Vijay Kulkarni, Co-Founder & Director, Swalava Enterprises Private Ltd.
12:15 - 12:45 Awards Amol Raje and Deveshwaran Arti Thakkar
12:45 - 13:00 Vote of Thanks
13:00 - 14:00 Lunch
About SSX India Image
About

SSX India


Indian Society for the Study of Xenobiotics (SSX) was established in 2016 as a non-profit association, with the mission of “increasing the awareness and developing the knowledge of DMPK/ADMET science to the Indian scientific community" by conducting annual conferences, workshops and DMPK-related courses. Our conference is one of the premier...
Read More
Our

Council Members

  • Council Member Image

    President

    Dr. Anandi Karumbati
  • Council Member Image

    Secretary

    Dr. Arti R. Thakkar
  • Council Member Image

    Treasurer

    Dr. T. Thanga Mariappan
  • Council Member Image

    Member

    Vamsi Madgula
  • Council Member Image

    Member

    Dr. Surulivel Rajan
  • Council Member Image

    Member

    Dr. Shashyendra Gautam
  • Council Member Image

    Member

    Dr. Manasa Deepa R
  • Council Member Image

    Member

    Dr. Amol A Raje
Contact SSX Image
Let’s Connect With Us
Address Society for the Study of Xenobiotics, Shop 1B, Site No. 1988, Nisarga Layout, Jigani, Bengaluru - 560083, India